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OBJECTIVE: The optimal strategy for fluid management during gastrointestinal surgery remains unclear. Minimizing
the variation in arterial pulse pressure, which is induced by mechanical ventilation, is a potential strategy to improve
postoperative outcomes. We tested this hypothesis in a prospective, randomized study with lactated Ringer’s
solution and 6% hydroxyethyl starch solution.
METHOD: A total of 60 patients who were undergoing gastrointestinal surgery were randomized into a restrictive
lactated Ringer’s group (n=20), a goal-directed lactated Ringer’s group (n=20) and a goal-directed hydroxyethyl
starch group (n=20). The goal-directed fluid treatment was guided by pulse pressure variation, which was recorded
during surgery using a simple manual method with a Datex Ohmeda S/5 Monitor and minimized to 11% or less by
volume loading with either lactated Ringer’s solution or 6% hydroxyethyl starch solution (130/0.4). The
postoperative flatus time, the length of hospital stay and the incidence of complications were recorded as
endpoints.
RESULTS: The goal-directed lactated Ringer’s group received the greatest amount of total operative fluid compared
with the two other groups. The flatus time and the length of hospital stay in the goal-directed hydroxyethyl starch
group were shorter than those in the goal-directed lactated Ringer’s group and the restrictive lactated Ringer’s
group. No significant differences were found in the postoperative complications among the three groups.
CONCLUSION: Monitoring and minimizing pulse pressure variation by 6% hydroxyethyl starch solution (130/0.4)
loading during gastrointestinal surgery improves postoperative outcomes and decreases the discharge time of
patients who are graded American Society of Anesthesiologists physical status I/II.
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INTRODUCTION
Fluid therapy is a routine practice during surgery;
however, the type, amount and timing of fluids adminis-
tered to patients who undergo major abdominal surgery are
under debate among anesthesiologists. The perioperative
fluid balance has been highlighted as a major contributory
factor in postoperative morbidity and mortality. Fluid
therapy strategies have been developed and implemented
in clinical practice over several decades. The data suggest
that aggressive or ‘‘liberal’’ intraoperative fluid resuscita-
tion is harmful during open abdominal operations, whereas
a restrictive fluid protocol has better outcomes, including
fewer postoperative complications and a shorter discharge
time (1-3). However, a restrictive fluid regimen has several
limitations (4). Overly restricted or inadequate fluid admin-
istration may lead to insufficient intravascular volume,
tissue hypoperfusion, cellular oxygenation impairment and
potential organ dysfunction (5), which will increase the
complication rate, hospital stay and mortality.
Recently, goal-directed fluid therapy has been the focus of
several studies on fluid therapy strategies. These studies
demonstrated a reduction in the postoperative complication
rate and the length of hospital stay with a goal-directed
strategy compared with a conventional strategy (6). How-
ever, few studies have examined the comparative outcome
performances of restrictive and goal-directed fluid therapy
in major intra-abdominal surgery; therefore, we conducted a
prospective, randomized, controlled study to compare the
length of postoperative hospital stay and the recovery of
bowel function in patients who were undergoing gastro-
intestinal surgery with either an intraoperative restrictive
or pulse pressure variation [PPV]-directed fluid therapy
protocol.
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MATERIALS AND METHODS
Subjects
After receiving approval from the institutional review
board of Huashan hospital and obtaining written informed
consent from the study participants, 60 patients who were
undergoing elective gastrointestinal surgeries with an antici-
pated blood loss of less than 500 ml were included in the
study. The inclusion criteria were patients with gastric or
colonic cancer who were 18-64 years of age. Patients with a
body mass index (BMI).30, significant arrhythmias, cardi-
opulmonary dysfunction, extensive peripheral arterial occlu-
sive disease, significant renal or liver diseases, pregnancy or
lactation and coagulopathy were excluded.
Anesthesia and monitoring
The surgery was preceded by an 8-hour fasting period.
Upon the arrival of the patients in the operating room, the
left side of the cubital vein was catheterized in all of the
patients. In addition to routing monitoring, including
noninvasive arterial blood pressure, electrocardiography
and pulse oximetry, invasive hemodynamic monitoring
(Datex Ohmeda S/5, Helsinki, Finland) was initiated in all
of the patients under local anesthesia. An A-line was
established via a 20-G catheter that was inserted in the
radial artery for invasive arterial pressure measurement. A
double-lumen central venous catheter (CV-17702, Arrow
International, Inc., Reading, PA) was inserted in the right
internal jugular vein to monitor the central venous pressure
(CVP). All of the monitoring transducers were positioned
and zeroed at the midaxillary level. The data registration
was excluded when a fast flush test indicated an unaccep-
table pressure recording. The heart rate, the mean arterial
pressure (MAP) and the CVP were continuously monitored
during the operation.
The induction of anesthesia was conducted with intrave-
nous (IV) midazolam (0.04 mg/kg), propofol (1.5-2 mg/kg)
and fentanyl (3 mg/kg). Succinylcholine (2 mg/kg) IV was
used to facilitate tracheal intubation. A volume-controlled
mode with zero end-expiratory pressure was used to ventilate
the lungs in all of the patients (Drager Julian, Philips
Healthcare, Tilburg, The Netherlands). The tidal volume
was maintained at 8-10 ml/kg, and the respiratory rate was
maintained at 10 beats/minute to maintain the end-tidal
carbon dioxide partial pressure at 35-40 mmHg. The venti-
lator settings were unchanged during the study. Patients
whose peak airway pressures exceeded 40 mmHg were
excluded from the study. Anesthesia was maintained with a
2.5-3% concentration of sevoflurane in O2, and fentanyl and
vecuronium were administered intermittently for intraopera-
tive analgesia and muscle relaxation. Immediately after
induction, all of the patients received 2.0 g of cefazolin
intravenously as an antibiotic prophylaxis. The body tem-
perature was maintained over 36 C˚ with a fluid warmer
throughout surgery. All of the surgeries in this study were
performed by the same surgical team.
Pulse pressure variation measurement
The PPV was measured using the simple tools in the
Datex Ohmeda S/5 Monitor as previously described (7,8).
The PPV (%) was calculated using the following formula:
PPV %ð Þ~200| PPmax{PPminð Þ= PPmaxzPPminð Þ
where PPmax and PPmin are the maximal and minimal pulse
pressure values, respectively, within one respiratory cycle.
The PPV (%) was calculated in triplicate over three
consecutive respiratory cycles. The mean value of the three
determinations was used for the analysis. As a reference for
fluid administration in the goal-directed therapy groups, the
PPV values were measured every 15 minutes during the
operation.
Grouping and fluid therapy protocol
Baseline measurements were instituted after induction
and hemodynamic stabilization. Next, the patients were
randomly assigned to one of three groups according to the
intraoperative fluid protocol using a random number
generator in sealed envelopes.
1. The restrictive Ringer’s lactate (R-RL) group (n = 20)
received a fixed infusion of 4 ml/kg per hour of lactated
Ringer’s solution exclusively throughout the operation.
The PPV was not measured in the R-RL group. If the
urine output was continuously ,0.5 ml/kg/h over two
hours or the CVP was less than 4 mmHg, 250-ml boluses
of lactated Ringer’s solution were administered until
these targets were restored.
2. The goal-directed Ringer’s lactate (GD-RL) group (n = 20)
received a fixed infusion of 4 ml/kg per hour of lactated
Ringer’s solution throughout the operation. In addition,
this group received 250 ml of lactated Ringer’s solution
as a bolus in 15 minutes if the PPV was .11%.
3. The goal-directed colloid (GD-C) group (n = 20) received
a fixed infusion of 4 ml/kg per hour of lactated Ringer’s
solution throughout the operation. In addition, this
group received 250 ml of 6% hydroxyethyl starch (HES,
130/0.4) as a bolus in 15 minutes if the PPV was .11%.
Intraoperative 4 ml/kg/h lactated Ringer’s solution was
infused continuously at a constant rate via an infusion
pump (TOP-3300H, TOP Corporation, Japan). The mean
arterial pressure was maintained within ¡20% of the
baseline value during the operation. Blood loss was
replaced with HES at a 1:1 ratio, and the blood transfusion
was started when clinically indicated and supported by
laboratory evidence of a hematocrit less than 28%.
Postoperative management
Anesthesia was discontinued when the operation was
completed. A total of 80 mg of parecoxib and 5 mg of
morphine was injected intravenously for analgesia 30 minutes
before the end of the surgery. Patients were extubated in the
operating room when they fulfilled the standard clinical
criteria (adequate protective reflexes, adequate oxygenation,
and stable hemodynamics). Once the patients were sent to the
ward, follow-up was conducted by an independent researcher
(Zhiyong He) who was unaware of the randomization of the
patient until the patient was discharged from the hospital. The
same surgical team was in charge of the postoperative care of
the patients, including fluid infusion (a baseline crystalloid
infusion of 1.5-2 ml/kg/h to maintain normovolemia with 2.0
grams of cefazolin daily for three days) and postoperative
analgesia (a daily intravenous infusion of 100 mg of flurbi-
profen axetil for three days following surgery and an
intramuscular injection of 10 mg of morphine as a rescue
analgesic). To treat postoperative nausea and vomiting, 10 mg
of metoclopramide was administered intravenously. The
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discharge criteria adopted the standard protocol that was
predefined by the Department of General Surgery at our
hospital.
The endpoints of the study
In this study, the primary endpoint was the postoperative
length of hospital stay, and the secondary endpoints were
the time to bowel flatus and postoperative complications.
Additionally, the preoperative and postoperative biochem-
ical and hemodynamic variables; the type and volume of the
intraoperative fluid infusions; the estimation of blood loss;
the urine output; and the medications were recorded.
Statistical analysis
To calculate the sample size, we used the retrospective
data that were available for the same surgical population at
our hospital. A one-day reduction in the postoperative
length of hospital stay was considered to be clinically
relevant, which required approximately 20 patients with a
type I error of 0.05 and a power of at least 90%.
The patient characteristics and the perioperative data
were analyzed using a one-way analysis of variance
(ANOVA), and the differences between the individual
treatment groups were determined using the Student–
Newman–Keuls test. The differences between the treatment
groups according to the incidence of adverse events were
determined using the two-tailed Fisher’s exact test. The
statistical analysis was performed using the SPSS 15.0
statistical software (SPSS, Inc., Chicago, IL). The statistical
significance was accepted at p,0.05.
RESULTS
A total of 60 patients with gastrointestinal cancer who
were undergoing laparotomy were enrolled. No patients
were excluded or dropped out of the study. There were no
significant differences between the groups regarding the
demographic characteristics and preoperative diseases
(Table 1).
The perioperative data are shown in Table 2. No
differences were observed between the types of surgery,
operation duration, intraoperative blood loss, and analgesic
consumption (fentanyl). However, the urine output in the
GD-RL group (485.0¡93.3 ml) was greater than that in the
other two groups (GD-C: 295.0¡48.4 ml, p,0.001; R-RL:
277.5¡63.8 ml, p,0.001). The patients in the GD-C group
required less vasopressors (phenylephrine or ephedrine)
than the patients in the GD-RL group (p= 0.001) or the R-RL
group (p,0.001). The amount of the intraoperative fluid
infusion in the GD-RL group (2109.50¡474.25 ml) was
significantly higher than those in the other groups (GD-C:
1742.50¡333.01 ml, p= 0.007; R-RL: 1260.00¡269.44 ml,
p,0.001) (Figure 1). Specifically, the GD-RL group (1853.0¡
381.3 ml) received more crystalloid solution than the GD-C
group (877.5¡130.0 ml, p,0.001) or the R-RL group
(1012.5¡238.4 ml, p,0.001), whereas the GD-C group
(865.0¡297.4 ml) received more colloid solution than the
GD-RL group (256.5¡139.9 ml, p,0.001) and the R-RL group
(252.5¡44.4 ml, p,0.001) (Figure 1). No patient required a
blood transfusion according to the hematocrit measurements
during the operation.
The baseline hematocrit, biochemical parameters (albu-
min and creatine levels) and hemodynamic variables (CVP
and PPV) were comparable among the three groups
(Table 2). Significant differences were found between the
hematocrit, albumin and PPV values at the end of surgery
and the baseline values in the GD-RL and GD-C groups
(Table 2).
The postoperative analgesic consumption, fluid adminis-
tration and complications were similar among the three
groups (p.0.05, Table 3). No anastomotic leaks or intra-
abdominal bleeding occurred, and all of the patients
survived during the study period. The time to first passage
of flatus was 86.2¡7.2 h in the GD-C group versus
92.1¡9.7 h (p= 0.03) in the R-RL group and 95.4¡9.1 h
(p,0.001) in the GD-RL group (Figure 2). The length of
postoperative hospital stay was 9.1¡1.4 days in the GD-C
group versus 10.9¡1.2 days (p,0.001) in the R-RL group
and 11.9¡1.2 days (p,0.001) in the GD-RL group (Figure 3).
DISCUSSION
Perioperative fluid replacement is a challenging issue in
surgical care, especially in a procedure-specific model.
Recently, goal-directed fluid therapy has been introduced
into clinical practice as part of perioperative management.
To our knowledge, this study is the first to directly compare
the effects of an intraoperative restrictive protocol with a
PPV-directed protocol on the outcomes of patients under-
going gastrointestinal surgery. Our results suggest that
PPV-directed therapy with HES solution results in a shorter
postoperative hospital stay and faster bowel function
recovery than an infusion with either restricted or PPV-
directed lactated Ringer’s solution. However, the incidence
of postoperative complications was similar among the
patients who were treated with the three fluid strategies.
The accuracy and early recognition of the intravascular
volume status is essential to prevent both hypoperfusion
due to volume depletion and fluid overload due to an
unnecessary infusion. Therefore, appropriate hemodynamic
monitoring is necessary for intraoperative fluid manage-
ment. A simple, affordable and reliable method to achieve
this goal would be appropriate for routine intraoperative
application. PPV measurement with a multiparameter
monitor that is commonly used in clinical practice has been
described and successfully used for intraoperative fluid
therapy (9,10). This type of PPV monitoring is not associated
Table 1 - Patient demographic data and clinical
characteristics.
GD-RL
(n= 20)
GD-C
(n = 20)
R-RL
(n= 20)
Age (yrs) 56.7¡6.9 52.8¡11.8 53.3¡13.0
Sex (M/F) 14/6 14/6 14/6
Height (cm) 167.1¡6.6 167.3¡9.4 165.0¡8.0
Weight (kg) 60.1¡10.7 62.9¡7.4 62.3¡9.6
ASA class (I/II) 11/9 10/10 11/9
Comorbidity
Diabetes 3 (15%) 2 (10%) 3 (15%)
Hypertension 5 (25%) 4 (25%) 3 (15%)
CAD 2 (10%) 1 (5%) 1 (5%)
COPD 4 (20%) 5 (20%) 3 (15%)
Asthma 1 (5%) 0 (0) 0 (0)
ASA: American Society of Anesthesiologists; CAD: coronary artery disease;
COPD: chronic obstructive pulmonary disease.
The data are presented as the means¡SD or the number (%).
Notes: All of the patients with comorbidities had been optimized before
anesthesia and surgery.
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with additional costs or complications other than arterial
catheterization. PPV monitoring has been recommended to
guide volume expansion in surgical patients. Lopes et al.
demonstrated that intraoperative PPV-guided fluid therapy
during high-risk surgery improved postoperative outcomes
and decreased the length of hospital stay (11). Our previous
studies demonstrated that the PPV, which was derived from
the Datex method, was comparable with the stroke volume
variation (SVV) using the FloTracTM/VigileoTM system (7)
and better than the CVP measurement (8) for intravascular
volume assessment. Therefore, we used PVV = 11%, which
was obtained from our previous study (7), as the threshold
of hypovolemia to target volume optimization in this study.
Many studies have investigated the effects of the amount
of intraoperative fluid administration on perioperative
outcomes. A meta-analysis demonstrated that a restrictive
intraoperative (3,12,13) and postoperative (14) fluid protocol
in major abdominal surgery reduces the incidence of
perioperative complications, such as cardiopulmonary
events and disturbances in bowel motility; improves wound
and anastomotic healing; and reduces the length of the
hospital stay. In addition, several studies examined the
effects of intraoperative fluid therapy that is guided by
various hemodynamic targets, such as conventional hemo-
dynamic parameter-guided and functional hemodynamic
parameter-directed fluid therapy, on perioperative out-
comes. Studies demonstrated that patient outcomes
improved after functional hemodynamic parameter (PPV
or SVV)-directed fluid therapy in major surgery (15-18).
Therefore, two optimal intraoperative strategies have been
proposed: restrictive and goal-directed fluid therapy.
However, patients who are treated using a goal-directed
Table 2 - Perioperative data.
GD-RL GD-C R-RL
Type of surgery
Gastrectomy 15 12 13
Colectomy 5 8 7
Duration of surgery (min) 190.3¡40.2 183.0¡13.8 182.5¡18.0
Blood loss (ml) 256.5¡139.9 265.0¡46.2 252.5¡44.4
Urine output (ml) 485.0¡93.3{ 295.0¡48.4 277.5¡63.8
Medications
Phenylephrine (mg) 120 (120-160) 80 (40-80) { 190 (180-200)
Ephedrine (mg) 12.5 (10-18.75) 5 (0-5) { 15 (15-20)
Fentanyl (mg) 625.0¡67.9 655.0¡48.4 660.0¡80.5
PPV value (%)
Baseline 13.6¡2.4 13.7¡2.1 –
End of surgery 7.1¡1.2* 7.0¡1.0* –
CVP value (mmHg)
Baseline 6.2¡1.1 6.3¡1.2 6.2¡1.0
End of surgery 8.7¡0.9 8.6¡1.0 7.8¡1.5
Albumin (g/l)
Preoperative 39.5¡2.5 40.0¡2.8 40.1¡3.5
First postoperative day 33.5¡2.1* 34.1¡2.0* 38.7¡2.9{
Creatine (mmol/l)
Preoperative 71.1¡8.0 66.8¡10.4 68.9¡10.6
First postoperative day 66.7¡8.1 61.4¡8.9 63.1¡10.2
Hematocrit (%)
Preoperative 41.9¡3.0 43.3¡3.8 42.5¡2.8
First postoperative day 35.9¡2.0* 38.8¡2.3* 41.3¡2.6{
HES: 6% hydroxyethyl starch (130/0.4); CVP: central venous pressure.
The data are presented as the means¡SD or the medians (25-75 interquartile range).
*, p,0.05, compared with the preoperative data; {, p,0.05, compared with the GD-RL group and the GD-C group.
Figure 1 - Intraoperative fluid infusion volume.
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protocol receive greater amounts of fluid than patients who
are treated with a restrictive protocol. Several studies
have questioned the positive effects of goal-directed fluid
therapy. Senagore et al. (19) revealed that esophageal
Doppler monitoring-guided fluid administration in laparo-
scopic colectomy predisposed patients to a longer hospital
stay and significantly increased complications. Lahner et al.
(20) demonstrated that SVV may not be a reliable predictor of
fluid responsiveness in the setting of major abdominal
surgery. PPV is considered to be more reliable than SVV
and can be used to recognize volume contraction earlier than
other indicators (21,22); however, amplified PPV does not
represent the hypovolemic status, such as anesthesia or
inflammation-induced vasodilation (10). Therefore, restric-
tive fluid infusion with vasopressor administration during
abdominal surgery has been advocated to prevent fluid
retention after the anesthetic effects have subsided. How-
ever, recent randomized trials did not confirm the potential
benefits of fluid restriction on recovery after elective surgery
(3,13). Intraoperative fluid restriction was associated with
frequent episodes of intraoperative hypovolemia (23), which
is a major determinant of postoperative organ dysfunction
(11) and an independent predictor of postoperative compli-
cations, such as an anastomotic leak and postoperative sepsis
(5). Whether goal-directed therapy is superior to a restrictive
fluid strategy in major abdominal surgery remains uncertain.
Therefore, we designed a prospective, randomized study to
compare the effects of restrictive and goal-directed fluid
therapy on perioperative outcomes in patients who were
undergoing open gastrointestinal surgery. The goal-directed
therapy group was further divided into two subgroups, a
GD-RL group and a GD-C group, to compare the role of fluid
type in intraoperative fluid therapy. In this study, a total fluid
volume of 1742 ml in the GD-C group was sufficient for
organ perfusion in open abdominal surgery over a 3-hour
period; however, a greater volume (2109 ml in the GD-RL
group) or reduced volume (1260 ml in the R-RL group) was
less effective.
Another factor that may influence the outcomes of
patients who undergo major abdominal surgery is the type
of fluid. In normovolemic healthy volunteers, the blood
volume expansion was significantly greater after an infusion
of 1 L of colloids (6% HES 130/0.4) than after an infusion of
1 L of crystalloids (saline) over one hour (24). Only 16% of
the HES solution and more than 68% of the saline solution
escaped into the extravascular fluid compartment after one
hour. In the setting of moderate hypovolemia, an infusion of
colloids increases blood volume and cardiac output more
effectively than the same volume of crystalloids, even when
the crystalloid infusion is rapidly administered (over 5-7
min) (25). Therefore, the patients in the GD-C group
required less vasoactivators to achieve hemodynamic
stability than the patients in the GD-RL and R-RL groups.
A greater volume (<1000 ml) of lactated Ringer’s solution
was infused into the GD-RL group to achieve PPV#11%
than that (<600 ml) of the HES solution in the GD-C group.
However, in contrast to the crystalloid-to-colloid volume
ratio of 4:1 or more, our results (RL: HES = 1.67) are
consistent with those of a recent study on goal-directed
resuscitation, in which lower ratios that ranged from 1-1.6
were observed (26). Crystalloids enter the extravascular
space more rapidly and in greater quantities than colloid;
therefore, third-space fluid accumulation and altered
capillary permeability may occur (23). Large amounts of
intravenous crystalloid solutions can lead to an interstitial
volume load, the development of interstitial edema and the
impairment of the diffusion of O2 in gut tissues (27), which
may prolong the period of ileus and increase postoperative
complications and thus undermine the healing process (12).
The large amounts of crystalloids that were administered in
the GD-RL group may have offset the beneficial effects of
the goal-directed therapy during the surgery. Subsequently,
the elimination of flatus and the postoperative discharge
times were delayed in the goal-directed crystalloid therapy
group compared with the restrictive regimen group (23).
Two studies have compared the outcomes between
intraoperative restrictive and goal-directed fluid manage-
ment strategies in animal experiments. Kimberger et al. (28)
demonstrated that goal-directed therapy with colloids
Table 3 - Postoperative data (n= 20).
GD-RL GD-C R-RL
Morphine consumption (mg) 61.7¡28.4 52.5¡30.2 59.0¡32.0
Fluid infusion volume per day (ml) 2342.5¡242.4 2442.5¡164.1 2412.5¡217.6
Complications
Postoperative vomiting 5 3 4
Arrhythmia* 1 0 0
Pulmonary infection 1 0 0
Bowel obstruction 0 0 1
SSI 1 1 0
Total complications 8 4 5
SSI: surgical site infection; Arrhythmia*: paroxysmal ventricular premature.
The data are presented as the means¡SD or the number.
Figure 2 - Time to first passage of flatus.
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significantly increased perianastomotic tissue oxygen ten-
sion compared with goal-directed crystalloid therapy and
restrictive crystalloid therapy after 4 hours of treatment in a
pig model of colon anastomosis surgery. In contrast to the
mucosal tissue, the microcirculatory blood flow in the
perianastomotic muscularis tissue was significantly higher
in the GD-C group compared with the GD-RL group.
Another study with the same fluid protocol found that the
hemodynamic parameters were significantly better in the
GD-C and GD-RL groups than in the R-RL group (29). The
microcirculatory flow and tissue oxygen tension in the
intestinal mucosa increased in the GD-C group but
remained unchanged or decreased in the GD-RL and R-RL
groups. These results suggest that goal-directed therapy
with colloids during gastrointestinal surgery can lead to
more stable intraoperative hemodynamics, faster bowel
function recovery and a shorter postoperative discharge
time compared with the goal-directed therapy with crystal-
loids in this study. However, several authors have ques-
tioned the beneficial role of goal-directed fluid therapy and
indicated that the better outcomes in the goal-directed
groups can be solely attributed to the larger amounts of
colloids that are used in these groups compared with the
control groups (30). Studies have demonstrated that the
beneficial local tissue effects are likely due to the anti-
inflammatory and antioxidant properties of colloids (HES
130/0.4), which augment the healing of anastomosis (31-34).
A restrictive colloid group was not included in our fluid
protocols; therefore, we cannot completely rule out the
possibility that additional colloids may have contributed to
our findings. However, in another experimental study with
a small bowel anastomosis rat model, Marjanovic et al. (35)
demonstrated that the animals that were treated with an
intraoperative crystalloid volume overcharge with a fixed
high flow rate exhibited worse anastomotic bursting
pressure and poor histological results (submucosal edema)
compared with the colloid overload group and the crystal-
loid or colloid volume restriction group that had a fixed low
flow rate. However, the colloid restriction group had only
comparable, but not better, results than the colloid overload
and crystalloid restriction groups.
There are several limitations to this study. The first
limitation is that an accelerated surgical recovery program
was not adopted. The morphine administration for post-
operative rescue analgesia may have affected the results
because this treatment can delay bowel function recovery
and cause PONV. Moreover, nasogastric tubes are routinely
applied during gastrointestinal surgery at our hospital.
However, the three groups in our series were similar with
respect to the surgeons (the same surgical team), clinical
characteristics and postoperative quality of care (conven-
tional but standardized). Second, we did not establish a
restrictive colloid group; therefore, the improvement in the
outcomes could be due to the fluid type rather than the fluid
therapy strategy. However, colloid replacement alone is not
recommended in the textbooks and guidelines on intrave-
nous fluid therapy in surgical patients. Finally, we did not
evaluate the 30-day mortality; however, there were no deaths
during the hospital stay of each patient. Additionally, this
study did not have the power to detect significant differences
in the cardiorespiratory outcomes because of the small
number of patients. Therefore, the clinical benefits of the
intraoperative goal-directed colloid strategy require further
assessment.
In summary, the PPV, which can be obtained using a
simple and inexpensive method, could be helpful in the
implementation of intraoperative goal-directed therapy.
Our data demonstrate that intraoperative treatment with
PPV-directed 6% HES (130/0.4) leads to more stable
hemodynamics, faster bowel function recovery and a
shorter postoperative hospital stay than treatment with
restrictive or PPV-directed lactated Ringer’s solution, which
suggests that intraoperative goal-directed therapy with
colloids may be beneficial in ASA I/II patients during
major gastrointestinal surgery. In addition, our results
support the use of intraoperative fluid therapy with the
accurate targeting of colloid fluid boluses, which prevents
excessive crystalloid administration, even in goal-directed
therapy. Relatively healthy and young adult patients
participated in this study; however, the effects of fluid
therapy strategies on the outcomes in elderly patients with
comorbidities (ASA III-IV) who undergo major abdominal
surgery remain unclear. Therefore, the explicit outcome
advantages of goal-directed colloid therapy in major surgery
warrant further study.
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